Rituximab versus Tocilizumab in anti-TNF inadequate responder patients with Rheumatoid Arthritis (R4RA): a stratified, biopsy-driven, multi-centre, randomised, open label, controlled clinical trial – 16 week outcomes
Frances Humby(Queen Mary University of London), Costantino Pitzalis(Queen Mary University of London), Bernard Lauwerys(UCB Pharma (Belgium)), Juan D. Cañete(Hospital Clínic de Barcelona), Vasco C. Romão(Unknown), Carlomaurizio Montecucco(University of Pavia), Giovanni Giorli(Queen Mary University of London), Peter Sasieni(Queen Mary University of London), Pier Paolo Sainaghi(Università degli Studi del Piemonte Orientale “Amedeo Avogadro”), Hasan Rizvi(Queen Mary University of London), Alberto Cauli(University of Cagliari), Felice Rivellese(Queen Mary University of London), Maya H Buch(Arthritis UK), John D. Isaacs(Newcastle upon Tyne Hospitals NHS Foundation Trust), Myles Lewis(Queen Mary University of London), R. J. Moots, Nagui Gendi(Basildon Hospital), Pauline Ho(Manchester Royal Infirmary), Bhaskar DasGupta(University of Cagliari), Ernest Choy(Cardiff University), Christopher J Edwards(University Hospital Southampton NHS Foundation Trust), Patrick Durez(Cliniques Universitaires Saint-Luc), Patrick Verschueren(Universitair Ziekenhuis Leuven), Stefano Bombardieri(University of Pisa), Stephen Kelly(Barts Health NHS Trust), Taylor Peter, Piero Reynolds(Homerton University Hospital), Arti Mahto(King's College Hospital NHS Foundation Trust), Nora Ng(Queen Mary University of London), Alessandra Nerviani(Queen Mary University of London)
Research Explorer (The University of Manchester)
January 1, 2020
Cited by 1
Related Papers
EULAR recommendations for the management of rheumatoid arthritis with synthetic and biological disease-modifying antirheumatic drugs: 2019 update
|Annals of the Rheumatic Diseases|2020|2.8k
EULAR recommendations for the management of rheumatoid arthritis with synthetic and biological disease-modifying antirheumatic drugs: 2022 update
|Annals of the Rheumatic Diseases|2022|1.9k
2022 update
|Radboud Repository (Radboud University)|2010|1.6k
A Randomized Trial of E-Cigarettes versus Nicotine-Replacement Therapy
|New England Journal of Medicine|2019|1.5k